Results summary | View all lists in GO:BiolProc | View all genes in D07A.profile.ud50 |
A biological process whose specific outcome is the progression of an integrated living unit: a cell, tissue, organ, or organism over time from an initial condition to a later condition. enrichment: 1.62-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
210260_S_AT | TNFAIP8 | G | tumor necrosis factor, alpha-induced protein 8 | ||||||||||
211959_AT | IGFBP5 | S | insulin-like growth factor binding protein 5 | ||||||||||
217999_S_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
203372_S_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
203543_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
208078_S_AT | SNF1LK | D | P | S | SNF1-like kinase | ||||||||
213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
217997_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
214439_X_AT | BIN1 | G | T | D | bridging integrator 1 | ||||||||
201110_S_AT | THBS1 | D | X | C | thrombospondin 1 | ||||||||
209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
205945_AT | IL6R | G | D | X | S | interleukin 6 receptor | |||||||
215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
203358_S_AT | EZH2 | D | P | R | enhancer of zeste homolog 2 (Drosophila) | ||||||||
203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
217996_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
209121_X_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
205486_AT | TESK2 | G | P | C | S | testis-specific kinase 2 | |||||||
218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
204924_AT | TLR2 | G | X | S | toll-like receptor 2 | ||||||||
201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
39402_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
201340_S_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) |